These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23484699)

  • 41. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
    Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
    J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
    Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
    Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal expression of p-ATM/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis.
    Ye Q; Chen H; Wen Z; Guo W; Huang Y; Mo X
    J Clin Pathol; 2021 Apr; 74(4):223-227. PubMed ID: 32220941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
    Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
    Go H; Jang JY; Kim CW; Huh J; Kim PJ; Jeon YK
    Leuk Lymphoma; 2020 Jan; 61(1):66-74. PubMed ID: 31441360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.
    Kwon JE; Kim BY; Kwak SY; Bae IH; Han YH
    Apoptosis; 2013 Jul; 18(7):896-909. PubMed ID: 23546867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
    Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression.
    Li D; Fu F; Lian L
    Neuropathology; 2018 Apr; 38(2):198-204. PubMed ID: 29063643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression.
    Zhang W; Qian JX; Yi HL; Yang ZD; Wang CF; Chen JY; Wei XZ; Fu Q; Ma H
    Mol Biol (Mosk); 2012; 46(4):622-7. PubMed ID: 23113351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8.
    Nijhuis A; Curciarello R; Mehta S; Feakins R; Bishop CL; Lindsay JO; Silver A
    Cell Tissue Res; 2017 May; 368(2):325-335. PubMed ID: 28190086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
    Ng SB; Chung TH; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Yin CC; Soong R; Jeyasekharan AD; Hoppe MM; Selvarajan V; Tan SY; Lim ST; Ong CK; Nairismägi ML; Maheshwari P; Choo SN; Fan S; Lee CK; Chuang SS; Chng WJ
    Haematologica; 2018 Feb; 103(2):278-287. PubMed ID: 29097495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients.
    Abrehdari-Tafreshi Z; Arefian E; Rakhshani N; Najafi SMA
    Biochem Genet; 2024 Feb; ():. PubMed ID: 38379036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of miR-363 on the proliferation, invasion and apoptosis of laryngeal cancer by targeting Mcl-1.
    Feng WT; Yao R; Xu LJ; Zhong XM; Liu H; Sun Y; Zhou LL
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4564-4572. PubMed ID: 30058689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of MiR101 and EZH2 in Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Lin YL; Zou ZK; Su HY; Huang YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):820-826. PubMed ID: 31204938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Skp2 in extranodal NK/T-cell lymphoma.
    Guo HQ; Pu XX; Guo CC; Rao HL; Li HR; Lin TY
    Chin J Cancer; 2010 May; 29(5):567-71. PubMed ID: 20426910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.
    Cheng D; Xu Y; Sun C; He Z
    Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population.
    McKelvie PA; Climent F; Krings G; Hasserjian RP; Abramson JS; Pilch BZ; Harris NL; Ferry JA; Zukerberg LR; Sohani AR
    Histopathology; 2016 Oct; 69(4):667-79. PubMed ID: 27144366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Value of PET/CT in the prognosis of extranodal NK/T cell lymphoma].
    Dong GH; Li Y; Wan HF; He CY; Yang L; Wang JW; Gong LP; Zhao YH; Gao ZF; Liu HG
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1256-1260. PubMed ID: 29747315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.